Semi-Annual Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7710547

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
As at
2017-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,536,000,000 JPY
2,136,000,000 JPY
Interest and dividends received
92,000,000 JPY
86,000,000 JPY
Interest paid
-229,000,000 JPY
-217,000,000 JPY
Income taxes paid
-348,000,000 JPY
-584,000,000 JPY
Net cash provided by (used in) operating activities
2,051,000,000 JPY
1,420,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,296,000,000 JPY
-961,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
743,000,000 JPY
Purchase of investment securities
-70,000,000 JPY
JPY
Proceeds from sale of investment securities
0 JPY
73,000,000 JPY
Other, net
-74,000,000 JPY
-166,000,000 JPY
Net cash provided by (used in) investing activities
-2,369,000,000 JPY
-984,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
4,900,000,000 JPY
4,600,000,000 JPY
Redemption of bonds
-38,000,000 JPY
-76,000,000 JPY
Repayments of long-term borrowings
-3,871,000,000 JPY
-3,456,000,000 JPY
Purchase of treasury shares
-6,000,000 JPY
-427,000,000 JPY
Dividends paid
-700,000,000 JPY
-706,000,000 JPY
Net cash provided by (used in) financing activities
-313,000,000 JPY
69,000,000 JPY
Other, net
-13,000,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
-630,000,000 JPY
506,000,000 JPY
Cash and cash equivalents
4,826,000,000 JPY
5,457,000,000 JPY
4,951,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.